Indee Labs (Winter 2017) - Startups.RIP

Back to all companies

Indee Labs (Winter 2017) - Startups.RIP

Back to all companies

Indee Labs

Winter 2017Active

Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.

Founded

Unknown

Category

Gene Therapy

YC Company Page www.indeelabs.com

No report yet — want us to research it?

This company has not been analyzed yet. Request a research report and we will email you when it is ready to view.

We will notify you as soon as the analysis is complete.